Newsadmin2025-04-07T10:16:14+00:00

News

Newly published study featuring our PODO/TERT256 cell line

Newly published study featuring our PODO/TERT256 cell line

Giulia Corso2024-09-26T11:49:21+00:00February 16th, 2024|

Evercyte contributing to reduce animal testing at key events

Evercyte contributing to reduce animal testing at key events

Giulia Corso2024-09-26T11:29:37+00:00December 7th, 2023|

Evercyte Showcases Expertise in Japan’s Pharma Landscape

Evercyte Showcases Expertise in Japan’s Pharma Landscape

Giulia Corso2024-09-26T11:30:10+00:00November 22nd, 2023|

Participation to the first MOVE symposium

Participation to the first MOVE symposium

Giulia Corso2024-09-26T11:30:28+00:00October 27th, 2023|

Participation to the Small New World 2.0 meeting

Participation to the Small New World 2.0 meeting

Giulia Corso2024-09-26T11:30:55+00:00September 19th, 2023|

RPTEC/TERT1 relevant kidney-on-a-chip model

RPTEC/TERT1 relevant kidney-on-a-chip model

Giulia Corso2023-09-19T07:33:39+00:00August 4th, 2023|

Previous 345 Next